Dr. Barrie J. Hurwitz reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Hurwitz is Associate Professor of Neurology and Associate Professor of Community and Family Medicine at Duke University Medical Center in Durham, North Carolina. He has served as principal investigator on several research projects regarding the treatment of multiple sclerosis, Parkinson's disease, and Guillain-Barré syndrome.
Education and Training
MB: Witwatersrand University Medical School, Johannesburg, South Africa, 1968
Internship in Medicine and Surgery: Johannesburg General Hospital, Witwatersrand University Medical School, Johannesburg, South Africa, 1968–1969
Senior House Officer in Medicine and Pediatrics: Johannesburg General Hospital, Witwatersrand University, Johannesburg, South Africa, 1970–1971
Residency in Internal Medicine, including Cardiology and Neurology Rotations: Johannesburg General Hospital, Witwatersrand University Medical School, Johannesburg, South Africa, 1971–1973
Fellowship in Neurology: Cornell University Medical College, New York, NY, 1974–1976
College of Physicians of South Africa
Royal College of Physicians (London, Glasgow, Edinburgh)
Neurology, American Board of Psychiatry and Neurology
American Board of Internal Medicine
Duke University Medical Center, Durham, NC:
Associate Professor, Community and Family Medicine, 1986–present
Associate Professor of Neurology, Department of Medicine, 1986–present
Assistant Professor, Community and Family Medicine, 1985–1986
Assistant Professor of Medicine (Neurology), 1978–1985
Clinical Assistant Professor in Neurology, Temple University, Philadelphia, PA, 1977–1978
Instructor in Neurology, Cornell University Medical College, New York, NY, 1976–1977
The final approval of Healthwise content is always made by a clinician with no financial conflicts.
This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the
how we develop our content .